NZ600527A - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number
NZ600527A
NZ600527A NZ600527A NZ60052708A NZ600527A NZ 600527 A NZ600527 A NZ 600527A NZ 600527 A NZ600527 A NZ 600527A NZ 60052708 A NZ60052708 A NZ 60052708A NZ 600527 A NZ600527 A NZ 600527A
Authority
NZ
New Zealand
Prior art keywords
inhibitors
compound
hcv
treating
antiviral compounds
Prior art date
Application number
NZ600527A
Inventor
Randall W Vivian
Zheng-Yu Yang
John O Link
Jeromy J Cottell
James Taylor
Scott D Schroeder
Winston C Tse
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of NZ600527A publication Critical patent/NZ600527A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

600527 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof of for treating a hepatitis C virus (CV). Additionally disclosed is a pharmaceutical composition comprising said compound, and optionally further comprising at least one additional therapeutic agent such as interferons, ribavirin analogs, NS3 protease inhibitors, NS5b polymerase inhibitors, alpha-glucosidase 1 inhibitors, hepatoprotectants, non-nucleoside inhibitors of HCV, and other drugs for treating HCV.
NZ600527A 2007-06-29 2008-06-26 Antiviral compounds NZ600527A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93775207P 2007-06-29 2007-06-29
US95969807P 2007-07-16 2007-07-16
NZ58209108 2008-06-26

Publications (1)

Publication Number Publication Date
NZ600527A true NZ600527A (en) 2014-01-31

Family

ID=50619563

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600527A NZ600527A (en) 2007-06-29 2008-06-26 Antiviral compounds

Country Status (1)

Country Link
NZ (1) NZ600527A (en)

Similar Documents

Publication Publication Date Title
IL195025A (en) Cyclopropyl fused indolobenzazepine derivatives and pharmaceutical compositions comprising the same as anti-hcv medicament
SV2005001920A (en) "NUCLEOSID COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS"
IL207468A (en) Hcv inhibitors and use thereof for the preparation of medicaments for treatment of hcv infections
WO2005007681A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2005077969A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
EP2431379A3 (en) HCV inhibitors
JP2011528713A5 (en)
WO2006039488A3 (en) Hcv ns3-ns4a protease inhibition
AR049635A1 (en) (1R, 2S, 5S) -N - ((1S) -3-AMINO-1- (CYCLLOBUTILMETIL) -2,3-DIOXOPROPIL) -3 - ((2S) -2 - (((((1,1-DIMETILETIL ) AMINO) CARBONIL) AMINO) -3,3-DIMETIL-1-OXOBUTIL) -6,6-DIMETIL-3-AZABICICLO (3.1.0) HEXAN-2-CARBOXAMIDE AS INHIBITOR OF THE NS3 / NS4A SERINA PROTEASA DEL VIRUS DE HEPATITIS C
MY164469A (en) Hcv ns3 protease inhibitors
WO2005037860A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
AR084393A1 (en) METHODS TO TREAT HEPATITIS C VIRUS, COMPOSITION, USE, COMBINATION, KIT AND ONE OR MORE ANTI HCV COMPOUNDS
NZ599284A (en) Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
WO2008002924A3 (en) Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
WO2008106058A3 (en) Inhibitors of serine proteases
PE20090228A1 (en) SULFUR COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS SERINE PROTEASE NS3
WO2004113365A3 (en) Hepatitis c serine protease tri-peptide inhibitors
BRPI0415935A (en) hcv treatment combinations
MX2010006210A (en) Fluorinated tripeptide hcv serine protease inhibitors.
WO2009053828A3 (en) P3 hydroxyamino macrocyclic hepatitis c serine protease inhibitors
JP2014504643A5 (en)
NZ592705A (en) 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
GEP20247600B (en) B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
UA95715C2 (en) Phosphadiazine derivatives, pharmaceutical composition and use thereof

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1302054, TAYLOR, JAMES; 1415831, TSE, WINSTON, C.; 1415834, SCHROEDER, SCOTT, D.; 3049364, VIVIAN, RANDALL, W., 1430 VIA VISTASAN MATEO, CA 94404, US; 3074143, COTTELL, JEROMY J., 701 BALTIC CIRCLE, #719, REDWOOD CITY, CALIFORNIA 94065, US; 3074160, LINK, JOHN O., 74 PROSPECT AVENUE, SAN FRANCISCO, CALIFORNIA 94110, US; 3074170, YANG, ZHENG-YU, 338 EL CARMELO AVENUE, PALO ALTO, CALIFORNIA 94306, US)

Effective date: 20140117

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 JUN 2015 BY AJ PARK

Effective date: 20140613

LAPS Patent lapsed